{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:01:53Z","timestamp":1776801713792,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,4]]},"DOI":"10.7759\/cureus.83447","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T11:47:21Z","timestamp":1746359241000},"source":"Crossref","is-referenced-by-count":1,"title":["Granulocyte Colony-Stimulating-Factor-Producing Bladder Carcinoma: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Kaori","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Shiseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155479","article-title":"G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation","volume":"142","author":"Karagiannidis I","year":"2021","unstructured":"Karagiannidis I, Salataj E, Said Abu Egal E, Beswick EJ. G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation. Cytokine. 2021, 142:155479. 10.1016\/j.cyto.2021.155479","journal-title":"Cytokine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)60308-2","article-title":"Leukemoid reaction, thrombocytosis and hypercalcemia associated with bladder cancer","volume":"110","author":"Block NL","year":"1973","unstructured":"Block NL, Whitmore WF. Leukemoid reaction, thrombocytosis and hypercalcemia associated with bladder cancer. J Urol. 1973, 110:660-3. 10.1016\/s0022-5347(17)60308-2","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-021-01130-8","article-title":"Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature","volume":"39","author":"Kohno S","year":"2021","unstructured":"Kohno S, Furuta A, Arizono S, et al.. Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature. Jpn J Radiol. 2021, 39:857-67. 10.1007\/s11604-021-01130-8","journal-title":"Jpn J Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000311","article-title":"Pembrolizumab treatment and pathologic therapeutic evaluation for granulocyte colony-stimulating factor-producing bladder cancer: a case report and literature review","volume":"43","author":"Muramatsu-Maekawa Y","year":"2020","unstructured":"Muramatsu-Maekawa Y, Taniguchi T, Ito H, et al.. Pembrolizumab treatment and pathologic therapeutic evaluation for granulocyte colony-stimulating factor-producing bladder cancer: a case report and literature review. J Immunother. 2020, 43:134-8. 10.1097\/CJI.0000000000000311","journal-title":"J Immunother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2023.03.025","article-title":"Bladder tumors with multiple cardiac metastases, with elevated serum granulocyte colony-stimulating factor","volume":"136","author":"Nagasaki N","year":"2023","unstructured":"Nagasaki N, Watanabe T, Edamura K, Araki M, Sadahira T. Bladder tumors with multiple cardiac metastases, with elevated serum granulocyte colony-stimulating factor. Am J Med. 2023, 136:e161-2. 10.1016\/j.amjmed.2023.03.025","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000502174","article-title":"Granulocyte colony-stimulating factor-producing bladder cancer","volume":"12","author":"Morinaga R","year":"2019","unstructured":"Morinaga R, Kawahara T, Kuroda S, Inayama Y, Uemura H. Granulocyte colony-stimulating factor-producing bladder cancer. Case Rep Oncol. 2019, 12:603-7. 10.1159\/000502174","journal-title":"Case Rep Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5152","article-title":"Trousseau's syndrome caused by bladder cancer producing granulocyte colony-stimulating factor and parathyroid hormone-related protein: a case report","volume":"12","author":"Kato T","year":"2016","unstructured":"Kato T, Yasuda K, Iida H, et al.. Trousseau's syndrome caused by bladder cancer producing granulocyte colony-stimulating factor and parathyroid hormone-related protein: a case report. Oncol Lett. 2016, 12:4214-8. 10.3892\/ol.2016.5152","journal-title":"Oncol Lett"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-8-147","article-title":"Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor--a potential neoplastic marker: a case report and review of the literature","volume":"8","author":"Kumar AK","year":"2014","unstructured":"Kumar AK, Satyan MT, Holzbeierlein J, Mirza M, Van Veldhuizen P. Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor--a potential neoplastic marker: a case report and review of the literature. J Med Case Rep. 2014, 8:147. 10.1186\/1752-1947-8-147","journal-title":"J Med Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.07.036","article-title":"Leukemoid reaction: a rare paraneoplastic syndrome in bladder cancer associated with a grave prognosis","volume":"83","author":"Shapiro DD","year":"2014","unstructured":"Shapiro DD, Potretzke A, Downs TM. Leukemoid reaction: a rare paraneoplastic syndrome in bladder cancer associated with a grave prognosis. Urology. 2014, 83:274-7. 10.1016\/j.urology.2013.07.036","journal-title":"Urology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/1119-3077.130256","article-title":"Leukemoid reaction associated with transitional cell carcinoma. A case report and literature review","volume":"17","author":"He H","year":"2014","unstructured":"He H, Zhang Z, Ge J, Zhou W. Leukemoid reaction associated with transitional cell carcinoma. A case report and literature review. Niger J Clin Pract. 2014, 17:391-4. 10.4103\/1119-3077.130256","journal-title":"Niger J Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.07.001","article-title":"Drug of the year: programmed death-1 receptor\/programmed death-1 ligand-1 receptor monoclonal antibodies","volume":"49","author":"Robert C","year":"2013","unstructured":"Robert C, Soria JC, Eggermont AM. Drug of the year: programmed death-1 receptor\/programmed death-1 ligand-1 receptor monoclonal antibodies. Eur J Cancer. 2013, 49:2968-71. 10.1016\/j.ejca.2013.07.001","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13127","article-title":"Leukemoid reaction: a 21st-century cohort study","volume":"42","author":"Portich JP","year":"2020","unstructured":"Portich JP, Faulhaber GA. Leukemoid reaction: a 21st-century cohort study. Int J Lab Hematol. 2020, 42:134-9. 10.1111\/ijlh.13127","journal-title":"Int J Lab Hematol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pop.2016.07.007","article-title":"Leukocytosis and leukemia","volume":"43","author":"Widick P","year":"2016","unstructured":"Widick P, Winer ES. Leukocytosis and leukemia. Prim Care Clin Office Pract. 2016, 43:575-87.","journal-title":"Prim Care Clin Office Pract"},{"key":"ref14","article-title":"Evaluation of patients with leukocytosis","volume":"92","author":"Riley LK","year":"2015","unstructured":"Riley LK, Rupert J. Evaluation of patients with leukocytosis. Am Fam Physician. 2015, 92:1004-11.","journal-title":"Am Fam Physician"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/iju5.12406","article-title":"Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma","volume":"5","author":"Takeda H","year":"2022","unstructured":"Takeda H, Matsumoto R, Takakuwa E, et al.. Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma. IJU Case Rep. 2022, 5:108-12. 10.1002\/iju5.12406","journal-title":"IJU Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10065-w","article-title":"Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study","volume":"22","author":"Miyazaki K","year":"2022","unstructured":"Miyazaki K, Shiba A, Ikeda T, et al.. Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study. BMC Cancer. 2022, 22:977. 10.1186\/s12885-022-10065-w","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00340","article-title":"Adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma: expanded efficacy from CheckMate 274","volume":"43","author":"Galsky MD","year":"2025","unstructured":"Galsky MD, Witjes JA, Gschwend JE, et al.. Adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma: expanded efficacy from CheckMate 274. J Clin Oncol. 2025, 43:15-21. 10.1200\/JCO.24.00340","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles T","year":"2024","unstructured":"Powles T, Valderrama BP, Gupta S, et al.. Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. N Engl J Med. 2024, 390:875-88. 10.1056\/NEJMoa2312117","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342579-granulocyte-colony-stimulating-factor-producing-bladder-carcinoma-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T11:47:22Z","timestamp":1746359242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342579-granulocyte-colony-stimulating-factor-producing-bladder-carcinoma-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.83447","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,4]]}}}